Chemistry:Tabernanthine
From HandWiki
Short description: Chemical compound
 | |
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C20H26N2O |
| Molar mass | 310.441 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Tabernanthine is an alkaloid found in Tabernanthe iboga.[1]
It has been used in laboratory experiments to study how addiction affects the brain.[2]
Tabernanthine persistently reduced the self-administration of cocaine and morphine in rats.[3]
Pharmacology
It is kappa opioid agonist (Ki = 0.15 μM) and NMDA receptor (Ki = 10.5 μM) antagonist.[4][5] Compared to ibogaine, it binds weakly to σ1 and σ2 receptor.[5]
See also
References
- ↑ "The Alkaloids of Tabernanthe iboga. Part IV.1 The Structures of Ibogamine, Ibogaine, Tabernanthine and Voacangine". Journal of the American Chemical Society 80: 126–136. 1958. doi:10.1021/ja01534a036.
- ↑ "A review of chemical agents in the pharmacotherapy of addiction". Current Medicinal Chemistry 9 (20): 1807–1818. October 2002. doi:10.2174/0929867023368980. PMID 12369879.
- ↑ "Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum". Brain Research 657 (1–2): 14–22. September 1994. doi:10.1016/0006-8993(94)90948-2. PMID 7820611.
- ↑ "Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies". Brain Research 571 (2): 242–247. February 1992. doi:10.1016/0006-8993(92)90661-r. PMID 1377086.
- ↑ 5.0 5.1 Lead Compounds from Medicinal Plants for the Treatment of Neurodegenerative Diseases. Academic Press. 16 December 2013. pp. 67–69, 73. ISBN 978-0-12-398383-1. https://books.google.com/books?id=o3opAgAAQBAJ&pg=PA67.
 |  |
